DOI QR코드

DOI QR Code

The role of thymic stromal lymphopoietin on mast cell-mediated allergic inflammatory reactions

  • Received : 2016.07.14
  • Accepted : 2016.08.16
  • Published : 2016.08.31

Abstract

Thymic stromal lymphopoietin (TSLP) is a novel interleukin (IL)-7-like cytokine and was originally discovered in the supernatant of a murine thymic stromal cell line. TSLP signal initiates via complex of the TSLP receptor and the IL-7 receptor α chain. TSLP expression is closely connected with many diseases such as atopic dermatitis, allergic rhinitis, asthma, inflammatory arthritis, eosinophilic esophagitis, rheumatoid arthritis, inflammatory bowel diseases, and cancer. In this review, I discussed biological roles of TSLP on mast cell-mediated allergic responses. In addition, this review summarizes the effective drugs in allergic-inflammatory reactions induced by TSLP on mast cells.

Keywords

INTRODUCTION

1. Mast cells

Mast cells play a critical role in the initiation and propagation of allergic inflammatory processes such as, allergic asthma, life-threatening anaphylaxis, inflammatory response, atopic dermatitis (AD), and allergic rhinitis (AR) (El-Agamy, 2012; Galli and Tsai, 2012). The cross-linking of IgE triggers mast cell de-granulation and the synthesis of a variety of mediators including biogenic amines, serglycin proteoglycans, serine proteases, cytokines, and growth factors (Plaut et al., 1989). Histamine released by mast cells evoked vascular permeabilization and hence enhances the migration of eosinophils, macrophages, and neutrophils into inflamed tissues (Oskeritzian et al., 2015). Thus, mast cell degranulation and activations intensifies and extends TH2-dependent inflammatory response (Galli and Tsai, 2012). Furthermore, interleukin (IL)-3, IL-5, IL-9, IL-6, tumor necrosis factor (TNF)-α, macrophage inflammatory protein-2, intercellular adhesion molecule-1, and thymic stromal lymphopoietin (TSLP) induce the recruitment of inflammatory cells leading to the late allergic response expressed by nasal congestion, chronic wheeze, and nasobronchial hyper-reactivity (Mandhane, 2011; Moon and Kim, 2011; Perlman, 1999; Xu et al., 1995). Intracellular signaling pathways such as mitogen-activated kinases and caspapase-1 regulate the production of these pro-inflammatory cytokines (Oh et al., 2012). The mRNA expressions of IL-1, IL-6, IL-8, TNF-α, and TSLP are induced by activation of a transcription factor, nuclear factor (NF)-κB. NF-κB bound to a specific consensus DNA element of promoter region increases the transcription of inflammatory cytokine genes (Jeong et al., 2002).

Mast cells are also multifunctional immune cells involved in the pathogenesis of various chronic inflammatory disorders, autoimmune diseases, and cancers (Galli and Tsai, 2012). Increased number of mast cells has been found in AD, AR, asthma, rheumatoid arthritis, tumor, and mast cell leukemia (El-Agamy, 2012; Galli and Tsai, 2012; Jeong et al., 2013). Mastocytosis is disorders determined by abnormal proliferation and accumulation of mast cells in various tissues, including liver, skin, gastrointestinal tract, bone marrow, spleen, and lymph nodes (Horny et al., 2008). The number of mast cells is increased by migration, proliferation, and survival (Kneilling and Röcken, 2009). Proliferation of mast cells was mainly induced by stem cell factor and IL-3 (da Silva et al., 2014). Recently, we have been demonstrated that TSLP also increased the proliferation of mast cells (Han et al., 2014a). Proliferation of mast cells exaggerates the several inflammatory diseases. Thus, inhibition of mast cell proliferation is regarded as an attractive therapeutic strategy for various inflammatory diseases.

2. TSLP

TSLP is a novel interleukin (IL)-7-like cytokine and was originally discovered in the supernatant of a murine thymic stromal cell line (Friend et al., 1994; Sims et al., 2000). TSLP has been known to promote Th2 cell-associated inflammation. TSLP is mostly expressed by epithelial cells of barrier surfaces in response to inflammatory cytokines, microbial products, or physical injury (Allakhverdi et al., 2007). The TSLP receptor (TSLPR) complex consists of a heterodimer of the IL-7 receptor α chain (IL-7Rα) and TSLPR (Pandey et al., 2000; Park et al., 2000). TSLP signaling is initiated by heterodimerization of the IL-7Rα and TSLPR (Pandey et al., 2000; Park et al., 2000). TSLP affects immune responses of nonhematopoietic and hematopoietic cell lineages, including mast cells, dendritic cells, natural killer, CD4+, and CD8+ T cells, basophils, eosinophils, epithelial cells, and B cells (Ziegler et al., 2013). TSLP is involved in the initiation and progression of numerous disorders including skin disorders, respiratory diseases, intestine inflammation, cancer, and autoimmune diseases (Ziegler et al., 2013). Mast cell activation via the TSLP produced by epithelial cells has a central function in allergic responses and it exacerbates infection and inflammation (Allakhverdi et al., 2007). TSLP is expressed and released by NF-κB and caspase-1 in activated mast cells (Moon and Kim, 2011). In addition, TSLP stimulation of mast cells leads to signal transducers and activators of transcription (STAT6) phosphorylation, murine double minute 2 (MDM2) expression, and IL-13 production and then increased mast cell-mediated allergic inflammatory reaction (Han et al., 2014a).

TSLP plays a pivotal role as a chief regulator of allergic inflammation in mice and human and is a new target for anti-allergic inflammatory therapy. In this review, we will focus on TSLP and describe how TSLP plays a role in development of allergic inflammation, and discuss TSLP as an attractive therapeutic target for allergic diseases.

2.1. TSLP in AD

TSLP was highly overexpressed by keratinocytes in the skin lesions of AD patients and mice (Soumelis et al., 2002; Corrigan et al., 2009). It causes the initiation of allergic inflammation by stimulating activation and infiltration of Langerhans cells into skin-draining lymph nodes (Soumelis et al., 2002; Zhang and Zhou, 2012). TSLP was also important for local antigen-induced Th2 cytokine production by directly acting on skin-infiltrating antigen-specific CD4+ T cells (He et al., 2008; Zhang and Zhou, 2012). Consistent with a requirement for TSLP in AD, challenged TSLPR deficient mice showed significantly decreased allergic skin inflammation, decreased eosinophils infiltration, and decreased Th2 cytokines expression compared with wild type mice in the skin (He et al., 2008). TSLP-deficient mice failed to generate AD development through the down-regulation of STAT6 and MDM2 (Han et al., 2014a).

2.2. TSLP in AR

TSLP is also critical factor for the pathophysiology of AR. In nasal epithelial cells, expression of TSLP was significantly higher in AR patients than in normal controls (Mou et al., 2008; Zhu et al., 2009; Kimura et al., 2011). TSLP level in nasal tissue biopsies was closely associated with IL-4 levels and AR severity (Mou et al., 2008). Highly TSLP levels were detected in nasal polyps of AR patients (Kimura et al., 2011; Liu et al., 2011).

3. Anti-allergic inflammatory effects of drugs via blockade of TSLP function

TSLP as a developmental factor of AD and AR was released and expressed by the intracellular calcium/caspase-1/ receptor-interacting protein 2/NF-κB pathways on mast cells (Han et al., 2012; Moon and Kim, 2011). Overexpressed-TSLP deteriorates the pathogenesis of AD and AR via the beginning of allergic inflammatory reactions (Han et al., 2014a; Oh et al., 2013a). TSLP stimulation of mast cells leads to STAT6 phosphorylation, murine double minute 2 expression, and IL-13 production and then increased mast cell-mediated allergic inflammatory reaction (Han et al., 2014a). Therefore, TSLP may be a useful therapeutic target for mast cell-mediated allergic diseases. Based on the inhibitory effect of TSLP production reported, drugs were shown in Table 1. Anti-proliferative effects of drugs on TSLP-induced the mast cell proliferation were also shown in Table 2.

Table 1.An inhibitory effect of drugs on TSLP production

Table 2.An inhibitory effect of drugs on TSLP-induced mast cell proliferation

 

CONCLUSION

The role of cytokines towards inflammation and modulation of various allergic diseases is a hot topic today. TSLP is an important factor in the pathogenesis of various allergic diseases and involved in the initiation and progression of allergic response. TSLP also induces the expression of a cascade of various potent inflammatory cytokines. Therefore, I suggested that TSLP is an attractive therapeutic target for allergic inflammatory diseases.

CONFLICT OF INTEREST

The authors state no conflict of interest.

References

  1. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204:253-258. https://doi.org/10.1084/jem.20062211
  2. Caglayan Sozmen S, Karaman M, Cilaker Micili S, Isik S, Arikan Ayyildiz Z, Bagriyanik A, Uzuner N, Karaman O. Resveratrol ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium. PeerJ. 2016;4:e1889. https://doi.org/10.7717/peerj.1889
  3. Corrigan CJ, Jayaratnam A, Wang Y, Liu Y, de Waal Malefyt R, Meng Q, Kay AB, Phipps S, Lee TH, Ying S. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects. Allergy. 2009;64:1014-1022. https://doi.org/10.1111/j.1398-9995.2009.01947.x
  4. da Silva EZ, Jamur MC, Oliver C. Mast cell function: a new vision of an old cell. J Histochem Cytochem. 2014;62:698-738. https://doi.org/10.1369/0022155414545334
  5. El-Agamy DS. Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions. Eur J Pharmacol. 2012; 680:115-121. https://doi.org/10.1016/j.ejphar.2012.01.039
  6. Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol. 1994;22:321-328.
  7. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18: 693-704. https://doi.org/10.1038/nm.2755
  8. Han NR, Go JH, Kim HM, Jeong HJ. Hyperoside regulates the level of thymic stromal lymphopoietin through intracellular calcium signalling. Phytother Res. 2014d;28:1077-1081. https://doi.org/10.1002/ptr.5099
  9. Han NR, Kang SW, Moon PD, Jang JB, Kim HM, Jeong HJ. Genuine traditional Korean medicine, Naju Jjok (Chung-Dae, Polygonum tinctorium) improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesional skin. Phytomedicine. 2014f;21:453-460. https://doi.org/10.1016/j.phymed.2013.09.021
  10. Han NR, Kim HM, Jeong HJ. The potential anti-proliferative effect of β-sitosterol on human mast cell line-1 cells. Can J Physiol Pharmacol. 2015;93:979-983. https://doi.org/10.1139/cjpp-2015-0166
  11. Han NR, Kim HM, Jeong HJ. The β-sitosterol attenuates atopic dermatitis-like skin lesions through down-regulation of TSLP. Exp Biol Med (Maywood). 2014c;239:454-64 https://doi.org/10.1177/1535370213520111
  12. Han NR, Kim HM, Jeong HJ. Thymic stromal lymphopoietin is regulated by the intracellular calcium. Cytokine. 2012;59:215-217. https://doi.org/10.1016/j.cyto.2012.04.015
  13. Han NR, Kim HM, Jeong HJ. Tryptanthrin reduces mast cell proliferation promoted by TSLP through modulation of MDM2 and p53. Biomed Pharmacother. 2016b;79:71-77 https://doi.org/10.1016/j.biopha.2016.01.046
  14. Han NR, Moon PD, Jeong HJ, Kim HM. Hydrogen sulfide diminishes the levels of thymic stromal lymphopoietin in activated mast cells. Arch Dermatol Res. 2016a;308:103-113 https://doi.org/10.1007/s00403-016-1619-x
  15. Han NR, Moon PD, Kim HM, Jeong HJ. Tryptanthrin ameliorates atopic dermatitis through down-regulation of TSLP. Arch Biochem Biophys. 2014e;542:14-20 https://doi.org/10.1016/j.abb.2013.11.010
  16. Han NR, Oh HA, Nam SY, Moon PD, Kim DW, Kim HM, Jeong HJ. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6. J Invest Dermatol. 2014a;134:2521-2530 https://doi.org/10.1038/jid.2014.198
  17. Han NR, Park JY, Jang JB, Jeong HJ, Kim HM. A natural dye, Niram improves atopic dermatitis through down-regulation of TSLP. Environ Toxicol Pharmacol. 2014b;38:982-990. https://doi.org/10.1016/j.etap.2014.10.011
  18. He R, Oyoshi MK, Garibyan L, Kumar L, Ziegler SF, Geha RS. TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proc Natl Acad Sci USA. 2008;105:11875-11880. https://doi.org/10.1073/pnas.0801532105
  19. Horny HP, Sotlar K, Valent P, Hartmann K. Mastocytosis: a disease of the hematopoietic stem cell. Dtsch Arztebl Int. 2008;105:686-692.
  20. Jeong HJ, Koo HN, Na HJ, Kim MS, Hong SH, Eom JW, Kim KS, Shin TY, Kim HM. Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells. Cytokine. 2002;18:252-259. https://doi.org/10.1006/cyto.2002.0894
  21. Jeong HJ, Nam SY, Oh HA, Han NR, Kim YS, Moon PD, Shin SY, Kim MH, Kim HM. Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro. Arthritis Res Ther. 2012;14:R259 https://doi.org/10.1186/ar4104
  22. Jeong HJ, Oh HA, Lee BJ, Kim HM. Inhibition of IL-32 and TSLP production through the attenuation of caspase-1 activation in an animal model of allergic rhinitis by Naju Jjok (Polygonum tinctorium). Int J Mol Med. 2014;33:142-150. https://doi.org/10.3892/ijmm.2013.1548
  23. Jeong HJ, Oh HA, Nam SY, Han NR, Kim YS, Kim JH, Lee SJ, Kim MH, Moon PD, Kim HM, Oh HA. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth. Int J Cancer. 2013;132:2492-2501. https://doi.org/10.1002/ijc.27937
  24. Kim MH, Jeong HJ. Zinc oxide nanoparticles demoted MDM2 expression to suppress TSLP-induced mast cell proliferation. J Nanosci Nanotecnol. 2016;16:2492-2498. https://doi.org/10.1166/jnn.2016.10785
  25. Kim MH, Seo JH, Kim HM, Jeong HJ. Aluminum-doped zinc oxide nanoparticles attenuate the TSLP levels via suppressing caspase-1 in activated mast cells. J Biomater Appl. 2016;30:1407-1416. https://doi.org/10.1177/0885328216629822
  26. Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, Okubo K. Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res. 2011;3:186-193. https://doi.org/10.4168/aair.2011.3.3.186
  27. Kneilling M, Röcken M. Mast cells: novel clinical perspectives from recent insights. Exp Dermatol. 2009;18:488-496. https://doi.org/10.1111/j.1600-0625.2009.00860.x
  28. Liu T, Li TL, Zhao F, Xie C, Liu AM, Chen X, Song C, Cheng L, Yang PC. Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis. Am J Med Sci. 2011;341:40-47. https://doi.org/10.1097/MAJ.0b013e3181f20489
  29. Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int Immunopharmacol. 2011;11:1646-1662. https://doi.org/10.1016/j.intimp.2011.07.005
  30. Moon PD, Choi IH, Kim HM. Berberine inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells. Int Immunopharmacol. 2011a;11:1954-1959. https://doi.org/10.1016/j.intimp.2011.08.004
  31. Moon PD, Choi IH, Kim HM. Epigallocatechin-3-O-gallate inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells. Amino Acids. 2012c;42:2513-2519. https://doi.org/10.1007/s00726-011-1050-8
  32. Moon PD, Choi IH, Kim HM. Naringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cells. Eur J Pharmacol. 2011b;671:128-132. https://doi.org/10.1016/j.ejphar.2011.09.163
  33. Moon PD, Jeong HJ, Kim HM. Down-regulation of thymic stromal lymphopoietin by curcumin. Pharmacol Rep. 2013;65:525-531. https://doi.org/10.1016/S1734-1140(13)71029-6
  34. Moon PD, Jeong HJ, Kim HM. Effects of schizandrin on the expression of thymic stromal lymphopoietin in human mast cell line HMC-1. Life Sci. 2012a;91:384-388. https://doi.org/10.1016/j.lfs.2012.08.009
  35. Moon PD, Kim HM. The suppression of thymic stromal lymphopoietin expression by selenium. Amino Acids. 2012b;43:999-1004 https://doi.org/10.1007/s00726-011-1156-z
  36. Moon PD, Kim HM. Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cells. Cytokine. 2011;54:239-243. https://doi.org/10.1016/j.cyto.2011.03.007
  37. Mou Z, Xia J, Tan Y, Wang X, Zhang Y, Zhou B, Li H, Han D. Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol. 2008;8:1-5.
  38. Nam SY, Oh HA, Choi Y, Park KY, Kim HM, Jeong HJ. Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis. J Med Food. 2014;17:939-948 https://doi.org/10.1089/jmf.2013.2996
  39. Oh HA, Han NR, Kim MJ, Kim HM, Jeong HJ. Evaluation of the effect of kaempferol in a murine allergic rhinitis model. Eur J Pharmacol. 2013a;718:48-56 https://doi.org/10.1016/j.ejphar.2013.08.045
  40. Oh HA, Ryu JG, Cha WS, Kim HM, Jeong HJ. Therapeutic effects of traditional Korean medicine, Jeechool-Whan in allergic rhinitis model. TANG. 2012;2: e9.
  41. Oh HA, Seo JY, Jeong HJ, Kim HM. Ginsenoside Rg1 inhibits the TSLP production in allergic rhinitis mice. Immunopharmacol Immunotoxicol. 2013b;35:678-686. https://doi.org/10.3109/08923973.2013.837061
  42. Oskeritzian CA, Hait NC, Wedman P, Chumanevich A, Kolawole EM, Price MM, et al. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses. J Allergy Clin Immunol. 2015;135:1008-1018. https://doi.org/10.1016/j.jaci.2014.10.044
  43. Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG, Ziegler SF, Leonard WJ, Lodish HF. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol. 2000;1:59-64.
  44. Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, Muller W, Largaespada DA, Copeland NG, Jenkins NA, Farr AG, Ziegler SF, Morrissey PJ, Paxton R, Sims JE. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med. 2000;192:659-670. https://doi.org/10.1084/jem.192.5.659
  45. Perlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol. 1999;104:S132-S136. https://doi.org/10.1016/S0091-6749(99)70308-8
  46. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature. 1989;339:64-67. https://doi.org/10.1038/339064a0
  47. Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V, Friend SL, Farr A, Bedell MA, Jenkins NA, Copeland NG, Grabstein K, Paxton RJ. Molecular cloning and biological characterization of a novel murine lymphoid lymphoid growth factor. J Exp Med. 2000;192:671-680. https://doi.org/10.1084/jem.192.5.671
  48. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673-680. https://doi.org/10.1038/nrm910
  49. Xu WB, Haddad EB, Tsukagoshi H, Adcock I, Barnes PJ, Chung KF. Induction of macrophage inflammatory protein 2 gene expression by interleukin 1β in rat lung. Throx. 1995;50:1136-1140.
  50. Yang G, An D, Lee MH, Lee K, Kim B, Suman CK, Ham I, Choi HY. Effect of Acer tegmentosum bark on atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol. 2016;177:53-60. https://doi.org/10.1016/j.jep.2015.10.033
  51. Yang G, Choi CH, Lee K, Lee M, Ham I, Choi HY. Effects of Catalpa ovata stem bark on atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol. 2013;145:416-423. https://doi.org/10.1016/j.jep.2012.10.015
  52. Yoou MS, Jin MH, Lee SY, Lee SH, Kim B, Roh SS, Choi IH, Lee MS, Kim HM, Jeong HJ. Cordycepin Suppresses Thymic Stromal Lymphopoietin Expression via Blocking Caspase-1 and Receptor-Interacting Protein 2 Signaling Pathways in Mast Cells. Biol Pharm Bull. 2016a;39:90-96 https://doi.org/10.1248/bpb.b15-00631
  53. Yoou MS, Kim HM, Jeong HJ. Acteoside attenuates TSLP-induced mast cell proliferation via down-regulating MDM2. Int Immunopharmacol. 2015;26:23-29. https://doi.org/10.1016/j.intimp.2015.03.003
  54. Yoou MS, Park CL, Kim MH, Kim HM, Jeong HJ. Inhibition of MDM2 expression by rosmarinic acid in TSLP-stimulated mast cell. Eur J Pharmacol. 2016b;771:191-198 https://doi.org/10.1016/j.ejphar.2015.12.025
  55. Zhu DD, Zhu XW, Jiang XD, Dong Z. Thymic stromal lymphopoietin expression is increased in nasal epithelial cells of patients with mugwort pollen sensitive-seasonal allergic rhinitis. Chin Med J (Engl). 2009;122:2303-2307.
  56. Ziegler SF, Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H. The biology of thymic stromal lymphopoietin (TSLP). Adv Pharmacol. 2013;66:129-155. https://doi.org/10.1016/B978-0-12-404717-4.00004-4